Your search returned 4 results.

Results
	1.	The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. [electronic resource] by Campbell, J D Spackman, D E Sullivan, S D Producer: 20110110 In: Allergy vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Health economics of asthma: assessing the value of asthma interventions. [electronic resource] by Campbell, J D Spackman, D E Sullivan, S D Producer: 20091130 In: Allergy vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Revisiting the cost-effectiveness of omalizumab. [electronic resource] by Campbell, J D Spackman, D E Sullivan, S D Producer: 20080122 In: Allergy vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis. [electronic resource] by Veenstra, D L Spackman, D E Di Bisceglie, A Bisceglie, A Kowdley, K V Gish, R G Producer: 20080801 In: Alimentary pharmacology & therapeutics vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search